Theranos Faces Rare Pre-IPO Securities Class Action

, The Recorder

   | 0 Comments

Hagens Berman partner Reid Kathrein, who filed the suit, said private investors sank more than $600 million into the beleaguered blood-testing startup based on false claims about its technology.

This premium content is reserved for The Recorder subscribers.

Continue reading by getting started with a subscription.

Already a subscriber? Log in now

What's being said

Comments are not moderated. To report offensive comments, click here.

Preparing comment abuse report for Article #1202773424131

Thank you!

This article's comments will be reviewed.